Cargando…
The prevalence of CMV and EBV among the patients with the colorectal cancer; a molecular approach
Autores principales: | Arastefar, Amir, Ranjbar, Reza, Behzad, Mohammad Amin, Dezfulian, Kamran, Mehr, Hamid Sharifi, Aein, Azin, Gholami, Mohsen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649347/ http://dx.doi.org/10.1186/2051-1426-3-S2-P379 |
Ejemplares similares
-
The prevalence of EBV and CMV DNA in epithelial ovarian cancer
por: Ingerslev, Kasper, et al.
Publicado: (2019) -
Prevalence of Cytomegalovirus (CMV) and Epstein-Barr Virus (EBV) Subclinical Infection in Patients with Acute Immune Thrombocytopenic Purpura (ITP)
por: Abbasi, Farshad, et al.
Publicado: (2021) -
Increasing the purity, potency and specificity of ebv-specific T cells to improve the treatment of EBV-positive lymphoma
por: Sharma, Sandhya, et al.
Publicado: (2015) -
Targeting cytomegalovirus (CMV) antigens for GBM immunotherapy
por: Nair, Smita K, et al.
Publicado: (2013) -
Monogenic interferonopathy presenting as CMV infection in infancy
por: Schütz, C, et al.
Publicado: (2015)